HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Kume Selected Research

Xenon-133

7/2000Relative preservation of peripheral lung function in smoking-related pulmonary emphysema: assessment with 99mTc-MAA perfusion and dynamic 133Xe SPET.
1/2000Irreversible long-term pulmonary functional impairments after adenovirus type-7 pneumonia: assessment with xenon-133 ventilation and Tc-99m MAA perfusion studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Kume Research Topics

Disease

14Atherosclerosis
12/2001 - 03/2000
3Atherosclerotic Plaque (Atheroma)
12/2001 - 06/2001
2Hemorrhage
10/2000 - 04/2000
1Body Weight (Weight, Body)
06/2011
1Overweight
06/2011
1Weight Loss (Weight Reduction)
06/2011
1Mental Disorders (Mental Disorder)
04/2003
1Inflammation (Inflammations)
12/2001
1Arteriosclerosis
10/2001
1Hyperplasia
10/2001
1Necrosis
08/2001
1Tuberculous Peritonitis
12/2000
1Pheochromocytoma
10/2000
1Lymphoma (Lymphomas)
07/2000
1Pulmonary Emphysema
07/2000
1Vascular Remodeling
06/2000
1Infarction (Infarctions)
06/2000
1Stroke (Strokes)
06/2000
1Hyperlipidemias (Hyperlipidemia)
05/2000
1Neuroblastoma
05/2000
1Thrombosis (Thrombus)
04/2000
1Pneumonia (Pneumonitis)
01/2000

Drug/Important Bio-Agent (IBA)

12oxidized low density lipoproteinIBA
06/2011 - 03/2000
5Chemokine CXCL16IBA
12/2001 - 12/2000
4LipidsIBA
06/2011 - 05/2001
4Lipoproteins (Lipoprotein)IBA
12/2001 - 05/2000
3Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA
06/2011 - 03/2000
2LectinsIBA
06/2011 - 08/2001
2Scavenger Receptors (Scavenger Receptor)IBA
12/2001 - 12/2000
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
05/2001 - 05/2000
2We 201IBA
05/2001 - 05/2000
2Phospholipids (Phosphatides)FDA LinkGeneric
05/2001 - 05/2000
2Radioisotopes (Radionuclides)IBA
12/2000 - 01/2000
23-Iodobenzylguanidine (Iobenguane)IBA
10/2000 - 05/2000
2Xenon-133IBA
07/2000 - 01/2000
1gamma-Aminobutyric Acid (GABA)IBA
04/2003
1PhosphatidylserinesIBA
12/2001
1CholesterolIBA
12/2001
1Fatty Acids (Saturated Fatty Acids)IBA
12/2001
1PPAR gammaIBA
12/2001
1PPAR alphaIBA
12/2001
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2001
1Transforming Growth Factor beta (TGF-beta)IBA
08/2001
1EndotoxinsIBA
08/2001
1Angiotensin IIIBA
08/2001
1CD68 MoleculeIBA
02/2001
1Class A Scavenger ReceptorsIBA
06/2000
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2000
1OximesIBA
06/2000
1Technetium Tc 99m Exametazime (Ceretec)FDA Link
06/2000
1Iodine-131IBA
05/2000
1platelet-derived growth factor AIBA
05/2000
1CatecholaminesIBA
05/2000
1Epidermal Growth Factor (EGF)IBA
05/2000
1Heparin (Liquaemin)FDA LinkGeneric
05/2000
1Iodine-123IBA
05/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2000
1Succimer (Dimercaptosuccinic Acid)FDA Link
04/2000
1Pentetic Acid (DTPA)FDA LinkGeneric
04/2000
1Cell Surface ReceptorsIBA
03/2000
1C-Type Lectins (C-Type Lectin)IBA
03/2000
1Membrane Proteins (Integral Membrane Proteins)IBA
03/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
07/2000 - 05/2000
1Caloric Restriction
06/2011
1Carotid Endarterectomy
11/2001
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2001
1Aftercare (After-Treatment)
05/2000